|
Delayed
Nasdaq
14:50:23 2026-11-05 EST
|
5-day change | 1st Jan Change | ||
| 1.598 USD | +11.74% |
|
-12.00% | -77.61% |
| 25-09-11 | GRI Bio Says Data Show No Lung Function Decline in Phase 2a Study of GRI-0621 in Idiopathic Pulmonary Fibrosis | MT |
| 25-04-01 | GRI Bio Prices up to $13 Million Equity Offering | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GRI BIOPAR | - | +11.74% | -12.00% | -77.61% | - | -99.08% | 3.01M |  | | |
- Stock Market
- Stocks
- GRI Stock
- Charts GRI BIOPAR
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
